期刊文献+

齐墩果酸对拉莫三嗪在大鼠体内药代动力学的影响

Effect of oleanolic acid on pharmacokinetics of lamotrigine in rats
原文传递
导出
摘要 目的通过建立测定拉莫三嗪(LTG)的血药浓度的UHPLC-MS/MS方法,探讨在大鼠体内单次使用和长期使用齐墩果酸对拉莫三嗪的药代动力学参数影响,进而探讨体内齐墩果酸对拉莫三嗪的药代动力学的影响。方法选用雄性SD大鼠,设置对照组、齐墩果酸单次给药组和齐墩果酸长期给药组,每组SD大鼠各8只进行造模,对大鼠血浆中拉莫三嗪的浓度进行检测,通过DAS 3.0计算各组拉莫三嗪的药代动力学参数,绘制药时曲线图,通过SPSS 23.0软件比较各组间拉莫三嗪的药代动力学参数的差异,研究齐墩果酸对拉莫三嗪药代动力学的影响。结果拉莫三嗪在0.05~10μg·mL^(-1)线性关系良好,日间、日内精密度均小于15%,回收率大于95%,稳定性较好。长期给药组的拉莫三嗪AUC_(0-t)为(347.36±181.03)μg·L^(-1)·h,C_(max)为(17.89±9.70)μg·L^(-1);单次给药组的拉莫三嗪AUC_(0-t)为(131.66±41.76)μg·L^(-1)·h,C_(max)为(8.74±3.05)μg·L^(-1);对照组的拉莫三嗪AUC_(0-t)为(91.95±42.07)μg·L^(-1)·h,C_(max)为(6.54±2.99)μg·L^(-1)。长期给药组的拉莫三嗪AUC_(0-t)明显增高,为对照组的3.8倍(P<0.05);C_(max)为对照组的2.7倍(P<0.05),同时清除率降低了70%(P<0.05),表明长期给药齐墩果酸明显抑制了拉莫三嗪在大鼠体内的代谢,提高了拉莫三嗪在体内的暴露量。单次给药组的拉莫三嗪AUC_(0-t)为对照组的1.4倍,C_(max)为对照组的1.3倍,但差异无统计学意义。结论齐墩果酸可抑制大鼠体内拉莫三嗪的代谢。临床上齐墩果酸与拉莫三嗪合用时,需考虑药物浓度变化的影响。 Objective To investigate the effect of oleanolic acid on the pharmacokinetics of lamotrigine(LTG) in rats by establishing a UHPLC-MS/MS method for the determination of lamotrigine in plasma. Methods Male SD rats were divided into control group, oleanolic acid single administration group and oleanolic acid long-term administration group, 8 rats in each group were used to establish the model, the concentration of lamotrigine in rat plasma was detected, the kinetic parameters of lamotrigine in each group were calculated by DAS 3.0, and the drug time curve was drawn. SPSS 23.0 was used to compare the differences of the pharmacokinetic parameters of LTG among the groups and study the effect on the pharma kinetic of lamotrigine afect by oleanolic. Results The linear range of lamotrigine was 0.05-10 μg·mL^(-1), the inter-day and intra-day precision were less than 15%,the recovery was more than 95%,and the stability was good. The AUC_(0-t) of lamotrigine in long-term administration group was( 347. 36 ± 181. 03) μg·L^(-1)·h,Cm ax was( 17. 89 ± 9. 70) μg·L^(-1);AUC_(0-t) in the single dose administration group was( 131. 66 ± 41. 76) μg·L^(-1)·h,Cm ax was( 8. 74 ± 3. 05) μg·L^(-1);AUC_(0-t) in control group was( 91. 95 ± 42. 07) μg·L^(-1)·h,Cm ax was( 6. 54 ± 2. 99) μg·L^(-1). AUC_(0-t) of lamotrigine in the long-term administration group was 3. 8 times higher than that in control group( P < 0. 05),Cm ax was 2. 7 times higher than that in control group( P < 0. 05),and clearence was decreased by 70%( P < 0. 05),indicating that long-term administration of oleanolic acid significantly inhibited the metabolism of lamotrigine in rats and increased the exposure of lamotrigine in vivo. The AUC_(0-t) and Cm ax of lamotrigine in the single dose administration group were 1. 4 and 1. 3 times higher than those in the control group,but there was no significant difference. Conclusion Oleanolic acid can inhibit lamotrigine metabolism in rats. When oleanolic acid is combined with lamotrigine in clinic,the effect of drug concentration should be considered.
作者 汪毅 王哲 林正锋 黄乙明 朱光辉 WANG Yi;WANG Zhe;LIN Zheng-feng;HUANG Yi-ming;ZHU Guang-hui(Department of Pharmacy,The 2rd Affiliated Hospital,Yuying Children's Hospital of Wenzhou Medical University,Wenzhou 325027,Zhejiang Province,China)
出处 《中国临床药理学杂志》 CAS CSCD 北大核心 2021年第17期2351-2354,共4页 The Chinese Journal of Clinical Pharmacology
基金 温州市科技局科研基金资助项目(Y20190660)。
关键词 拉莫三嗪 药代动力学 齐墩果酸 UHPLC-MS/MS lamotrigine pharmacokinetics oleanolic acid UHPLC-MS/MS
  • 相关文献

参考文献1

二级参考文献20

  • 1Okada K, Tamura Y, Yamamoto M, et al. Identification of antimicrobial and antioxidant constituents from licorice of Russian and Xiniiang nrigin[J]. Chem Pharm Bull (Tokyo), 1989, 37(9) :2528-2530.
  • 2Vaya J,Belinky PA, Aviram M. Antioxidant constituents from licorice roots: isolation, structure elucidation and antioxidative capacity toward LDL oxidation[J]. Free Radie Biol Med, 1997,23:302-313.
  • 3Ablise M, Rena Kasimu R, Ma SY, et al. Isolation and antioxidant property of glabridin[J]. Nat Pro Res Dev, 2007,19 (4) :675-682.
  • 4Mira R, Paula B,Jacob V, et al. Macrophage enrichment with the isoflavan glabridin inhibits NADPH oxidase-induced cell- mediated oxidation of low density lipoprotein[J]. J Biol Chem, 1999, 274(20) :13790-13799.
  • 5Vaya J,Paula AB. Antioxidan't constituents from licorice roots: isolation, structure elucidation and antioxidative capacityt to- ward LDL oxidation[J]. Free Radie Biol Med, 1997, 23(2) : 302.
  • 6Fuhrman B, Nina V. Antiatherosclerotic effects of licorice extracts supplementation on hypereholesterolemic patients: increased resistance of LDL to atherogenic modifications, reduced plasma lipid levels, and deereaed systolic blood pressure [J]. Nutrition, 2002,18:268.
  • 7Fuhrman B, Buch S, Vaya J, et al. Licorice extract and its major polyphenol, glabridin protect low-density lipoprotein against lipid peroxidation: in vitro and ex vivo studies in humans and in atherosclerotic apolipoprotein E-deficient mice[J]. Am J Clin Nutr, 1997,66(2) :267-275.
  • 8Aoki F, Nakagawa K, Kitano M,et al. Clinical safety of licorice flavonoid oil (LFO) and pharmacokinetics of glabridin in healthy humans[J]. J AmCollNutr, 2007,26(3) :209-218.
  • 9Yu XQ, Xue CC, Zhou ZW, et al. In vitro and in vivo neuroprotective effect and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra (licorice)[J]. Life Sci, 2008,82(1-2) :68-78.
  • 10Cui YM, Ao MZ, Li W, et al. Effect of glabridin from glycyrrhiza glabra on learning and memory in mice[J]. Planta Med, 2008, 74(4):377-380.

共引文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部